Glyceollins inhibit platelet-derived growth factor-mediated human arterial smooth muscle cell proliferation and migration

British Journal of Nutrition

Volumn 107, Issue 1, 2012, Pages 24-35

  Kim, Hyo Jung ^a   Cha, Byung Yoon ^b   Choi, Bongkeun ^c   Lim, Ji Sun ^a   Woo, Je Tae ^b   Kim, Jong Sang ^a  

^a Kyungpook National University   (South Korea)

^b CHUBU UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Glyceollins; Migration; Platelet derived growth factor signal pathway; Platelet derived growth factor BB; Proliferation; Smooth muscle cells

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLYCEOLLIN I; GLYCEOLLIN II; GLYCEOLLIN III; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA1; PHYTOALEXIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN AORTIC SMOOTH MUSCLE CELL; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANGIOGENESIS INDUCING AGENTS; ANTIOXIDANTS; ARTERIES; CARDIOVASCULAR DISEASES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-SIS; PTEROCARPANS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ASPERGILLUS SOJAE;

EID: 84862969121     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002571     Document Type: Article

References (70)

1. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809. (Pubitemid 23132154)
2. Raines EW (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev 5, 237-254. (Pubitemid 38781049)
3. Jiang B, Yamamura S, Nelson PR, et al. (1996) Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery 120, 427-431.
4. Koyama N, Hart CE & Clowes AW (1994) Different functions of the platelet-derived growth factor-a and-b receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res 75, 682-691. (Pubitemid 24297639)
5. Sirois MG, Simons M & Edelman ER (1997) Antisense oligo-nucleotide inhibition of PDGFR-b receptor subunit expression directs suppression of intimal thickening. Circulation 95, 669-676. (Pubitemid 27063045)
6. Jawien A, Bowen-Pope DF, Lindner V, et al. (1992) Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89, 507-511.
7. Banai S (1998) PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 97, 1960-1969. (Pubitemid 28222191)
8. Bornfeldt KE, Raines EW, Nakano T, et al. (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93, 1266-1274. (Pubitemid 24087183)
9. Bornfeldt KE, Raines EW, Graves LM, et al. (1995) Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 766, 416-430. (Pubitemid 26169122)
10. Sundaresan M, Yu ZX, Ferrans VJ, et al. (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
11. Lephart ED, West TW, Weber KS, et al. (2002) Neurobeha-vioral effects of dietary soy phytoestrogens. Neurotoxicol Teratol 24, 5-16. (Pubitemid 34143245)
12. Lund TD, West TW, Tian LY, et al. (2001) Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci 2, 20.
13. Nagata C, Shimizu H, Takami R, et al. (1999) Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric 2, 6-12. (Pubitemid 29253920)
14. Nagata C, Takatsuka N, Kawakami N, et al. (2001) Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 153, 790-793. (Pubitemid 32319707)
15. Anderson JJ & Garner SC (1998) Phytoestrogens and bone. Ball Clin Endocrinol Metabiol 12, 543-557. (Pubitemid 29261270)
16. Lichtenstein A (1998) Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128, 1589-1592. (Pubitemid 28452838)
17. Wiseman H, O'Reilly JD, Adlercreutz H, et al. (2000) Isofla-vone phytoestrogens consumed in soy decrease F2-isopros-tane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72, 395-400. (Pubitemid 30620644)
18. Mortensen A, Kulling SE, Schwartz H, et al. (2009) Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res 53, 266-309.
19. Zava DT & Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27, 31-40. (Pubitemid 26424313)
20. Davis JN, Singh B, Bhuiyan M, et al. (1998) Genistein-induced upregulation of p21WAFI, downregulation of cyclin b, and induction of apoptosis in prostate cancer cells. Nutr Cancer 32, 123-131. (Pubitemid 29081398)
21. Onozawa M, Fukada K, Ohthani M, et al. (1998) Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn J Clin Oncol 28, 360-363. (Pubitemid 128522964)
22. Dubey RK, Gillespie DG, Imthurn B, et al. (1999) Phytoestro-gens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33, 177-182. (Pubitemid 29065656)
23. Pignatelli P, Pulcinelli FM, Lenti L, et al. (1998) Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 91, 484-490. (Pubitemid 28053370)
24. Davis JN, Kucuk O, Djuric Z, et al. (2001) Soy isoflavone supplementation in healthy men prevents NF-kB activation by TNF-a in blood lymphocytes. Free Radic Biol Med 30, 1293-1302. (Pubitemid 32463940)
25. Satake N & Shibata S (1999) The potentiating effect of genis-tein on the relaxation induced by isoproterenol in rat aortic rings. Gen Pharmacol 33, 221-227. (Pubitemid 29376459)
26. Weber C, Negrescu E, Erl W, et al. (1995) Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 155, 445-451.
27. Gottstein N, Ewins BA, Eccleston C, et al. (2003) Effect of genistein and daidzein on platelet aggregation and mono-cyte and endothelial function. Br J Nutr 89, 607-616.
28. Payton-Stewart F, Schoene NW, Kim YS, et al. (2009) Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Mol Carcinog 48, 862-871.
29. Salvo VA (2006) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12, 7159-7164. (Pubitemid 44974517)
30. Brent KJ & Hollomon DW (1998) Fungicide Resistance: The Assessment of Risk. Monograph No. 2. Brussels: Global Crop Protection Federation.
31. Costa TR, Fernandes FLF, Santos SC, et al. (2000) Antifungal activity of volatile constituents of Eugenia dysenterica leaf oil. J Ethnopharmcol 72, 111-117.
32. Kim HJ, Suh HJ, Kim JH, et al. (2010) Estrogenic activity of glyceollins isolated from soybean elicited with Aspergillus sojae. J Med Food 13, 382-390.
33. Cha BY, Shi WL, Yonezawa T, et al. (2009) An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci 110, 105-110.
34. Erl W (2000) Pyrrolidine dithiocarbamate-induced apopto-sis depends on cell type, density, and the presence of Cu2 + and Zn2 +. Am J Physiol Cell Physiol 278, 1116-1125.
35. Mu H, Ohashi R, Yang S, et al. (2006) Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. Cell Motil Cytoskeleton 63, 222-230.
36. Wang H & Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27, 612-616. (Pubitemid 29408648)
37. Li W, Miller F, Brown M, et al. (2000) Enhanced H2O2-induced cytotoxicity in "epithelioid" smooth muscle cells: implications for neointimal regression. Arterioscler Thromb Vasc Biol 20, 1473-1479. (Pubitemid 30353876)
38. WedgwoodS&BlackSM (2004) Combined superoxide dismu-tase/catalase mimetics alter fetal pulmonary arterial smooth muscle cell growth. Antioxid Redox Signal 6, 191-197. (Pubitemid 38063991)
39. Parinandi NL, Kleinberg MA, Usatyuk PV, et al. (2003) Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 284, 26-38.
40. Arts IC & Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, Suppl. 1, 317S-325S.
41. Stangl V, Dreger H, Stangl K, et al. (2007) Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 73, 348-358. (Pubitemid 44937692)
42. Heber D (2001) Herbs and atherosclerosis. Curr Atheroscler Rep 3, 93-96.
43. Kim TJ, Zhang YH, Kim Y, et al. (2002) Effects of apigenin on the serum-and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Med 68, 605-609. (Pubitemid 34827925)
44. Rosenkranz S, Knirel D, Dietrich H, et al. (2002) Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox". FASEB J 16, 1958-1960.
45. Miller NJ & Ruiz-Larrea MB (2002) Flavonoids and other plant phenols in the diet: their significance as antioxidants. J Nutr Environ Med 12, 39-51. (Pubitemid 34327131)
46. Jiang P, Liu J, Li W, et al. (2010) Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Acta Biochim Biophys Sin (Shanghai) 42, 671-676.
47. Sosroseno W, Bird PS & Seymour GJ (2003) Intracellular proteins involved in Porphyromonas gingivalis-induced opsonophagocytic activities of a murine macrophage cell line (RAW264·7 cells). J Microbiol Immunol Infect 36, 229-235. (Pubitemid 38076026)
48. Pan W, Ikeda K, Takebe M, et al. (2001) Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Nutr 131, 1154-1158. (Pubitemid 32275092)
49. Yu JY, Lee JJ, Lim Y, et al. (2008) Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J Pharmacol Sci 107, 90-98. (Pubitemid 351744087)
50. Kim HJ, Suh HJ, Kim JH, et al. (2010) Antioxidant activity of glyceollins derived from soybean elicited with Aspergillus sojae. J Agric Food Chem 24, 11633-11638.
51. Zimmermann MC, Tilghman SL, Boué SM, et al. (2010) Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther 332, 35-45.
52. Payton-Stewart F, Khupse RS, Boué SM, et al. (2010) Glyceol-lin I enantiomers distinctly regulate ER-mediated gene expression. Steroids 75, 870-878.
53. Braun-Dullaeus RC, Mann MJ, Sedding DG, et al. (2004) Cell cycle-dependent regulation of smooth muscle cell activation. Arterioscler Thromb Vasc Biol 24, 845-850. (Pubitemid 38620861)
54. Sherr CJ (1996) Cancer cell cycles. Science 274, 1672-1677.
55. Sherr CJ & Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512. (Pubitemid 29297917)
56. Jirawatnotai S, Aziyu A, Osmundson EC, et al. (2004) Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem 279, 51100-51106. (Pubitemid 40017852)
57. Martin A, Odajima J, Hunt SL, et al. (2005) Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1. Cancer Cell 7, 591-598. (Pubitemid 40799251)
58. Akiyama T, Ohuchi T, Sumida S, et al. (1992) Phosphoryl-ation of retinoblastoma protein by CDK2. Proc Natl Acad Sci USA 89, 7900-7904.
59. Connell-Crowley L, Elledge SJ & Harper JW (1998) G1 cyclin dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblast. Curr Biol 8, 65-68. (Pubitemid 28056255)
60. Brooks EE, Gray NS, Joly A, et al. (1997) CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 272, 29207-29211. (Pubitemid 27498212)
61. Sasaguri T, Ishida A, Kosaka C, et al. (1996) Phorbolester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells. J Biol Chem 271, 8345-8351. (Pubitemid 26108669)
62. Heldin CH & Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79, 1283-1316. (Pubitemid 29473317)
63. Brown DI & Griendling KK (2009) Nox proteins in signal transduction. Free Radic Biol Med 47, 1239-1253.
64. Sundaresan M, Yu ZX, Ferrans VJ, et al. (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
65. Choi MH, Lee IK, Kim GW, et al. (2005) Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435, 347-353. (Pubitemid 40745544)
66. Hsieh CY, Liu CL, Hsu MJ, et al. (2010) Inhibition of vascular smooth muscle cell proliferation by the vitamin E derivative pentamethylhydroxychromane in an in vitro and in vivo study: pivotal role of hydroxyl radical-mediated PLCg1 and JAK2 phosphorylation. Free Radic Biol Med 49, 8881-8893.
67. Adachi M, Katsumura KR, Fujii K, et al. (2003) Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett 554, 77-80. (Pubitemid 37324818)
68. Chen XW, Garner SC & Anderson JJB (2002) Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 295, 417-422. (Pubitemid 34785851)
69. Chacko BK, Chandler RT, Mundhekar A, et al. (2005) Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 289, 908-915.
70. Arai Y, Uehara M, Sato Y, et al. (2000) Comparison of isofla-vones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10, 127-135.